Search Results - "KLIGERMAN, M M"

Refine Results
  1. 1

    Use of radiation with or without WR-2721 in advanced rectal cancer by Liu, T, Liu, Y, He, S, Zhang, Z, Kligerman, M M

    Published in Cancer (01-06-1992)
    “…One hundred patients with inoperable, unresectable, or recurrent adenocarcinoma of the rectum were stratified and randomized to WR-2721 plus radiation therapy…”
    Get more information
    Journal Article
  2. 2

    Integrating Laser Surface Mapping with CBCT for Enhanced Decision Support from ML Guided Resimulation Predictions by Shang, S., Evans, G., Kligerman, M., Shang, M., Williams, T.R., Shang, C.Y.

    “…The study's primary objective is to evaluate the comparability of C-RAD Surface Mapping Images (SMI) scores with traditional CT Surface Mapping (CTSM) scores…”
    Get full text
    Journal Article
  3. 3

    Decreased acute toxicity by using midline mucosa-sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx, and nasopharynx by Perch, S J, Machtay, M, Markiewicz, D A, Kligerman, M M

    Published in Radiology (01-12-1995)
    “…To determine whether midline mucosa-sparing blocks (MSBs) protecting the aerodigestive tract can statistically significantly reduce acute toxicity during…”
    Get more information
    Journal Article
  4. 4

    Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument by Jones, Heather A, Hershock, Diane, Machtay, Mitchell, Chalian, Ara A, Weber, Randal S, Weinstein, Gregory S, Schumacher, Karen, Kligerman, Morton M, Berlin, Jessie A, Rosenthal, David I

    Published in American journal of clinical oncology (01-04-2006)
    “…Observations indicate that the acute toxicity of chemoradiation for squamous cell carcinoma (SCC) of the head and neck is not the same as that which occurs…”
    Get full text
    Journal Article
  5. 5

    Variation in parotid gland size, configuration, and anatomic relations by Medbery, Robbie, Yousem, David M, Needham, Michael F, Kligerman, Morton M

    Published in Radiotherapy and oncology (2000)
    “…Purpose: To examine the variation in the anatomy of parotid glands discerned by magnetic resonance imaging. Methods: Head and neck magnetic resonance scans of…”
    Get full text
    Journal Article
  6. 6

    Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer by Bucci, Mary K, Rosenthal, David I, Hershock, Diane, Metz, James, Devine, Pamela, Kligerman, Morton M, Machtay, Mitchell

    Published in American journal of clinical oncology (01-12-2004)
    “…Recent data show that accelerated radiotherapy (XRT) improves local-regional control (LRC) over standard-fractionation XRT. Concurrent chemoradiotherapy…”
    Get full text
    Journal Article
  7. 7

    WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial by Glover, D, Glick, J H, Weiler, C, Hurowitz, S, Kligerman, M M

    Published in Journal of clinical oncology (01-04-1986)
    “…WR-2721 S-2-(3-aminopropylamino) ethyl phosphorothioic acid, is an organic thiophosphate compound that in the animal model selectively protects against the…”
    Get more information
    Journal Article
  8. 8

    Radiotherapy with 6-megavolt photons for early glottic carcinoma: Potential impact of extension to the posterior vocal cord by Lee, Jason H., Machtay, Mitchell, McKenna, Michael G., Weinstein, Gregory S., Markiewicz, Deborah A., Krisch, Robert E., Kligerman, Morton M.

    Published in American journal of otolaryngology (01-01-2001)
    “…Purpose: Radiation therapy has a high success rate in the treatment of early glottic carcinoma. Excellent outcomes have been reported from centers using…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease by Matsubara, Tomoyo, Mason, Wilbert, Kashani, Iraj A., Kligerman, Morton, Burns, Jane C.

    Published in The Journal of pediatrics (01-05-1996)
    “…Although gastrointestinal hemorrhage is a well-recognized complication of aspirin therapy, this side effect has not been previously reported in patients with…”
    Get full text
    Journal Article
  11. 11

    Evaluation of multileaf collimator design for a photon beam by Galvin, J M, Smith, A R, Moeller, R D, Goodman, R L, Powlis, W D, Rubenstein, J, Solin, L J, Michael, B, Needham, M, Huntzinger, C J

    “…Various aspects of multileaf collimator (MLC) design are examined relative to clinical requirements. The characteristics studied included: (a) irregular field…”
    Get more information
    Journal Article
  12. 12

    Interim analysis of a randomized trial of radiation therapy of rectal cancer with/without WR-2721 by Kligerman, M M, Liu, T, Liu, Y, Scheffler, B, He, S, Zhang, Z

    “…The objectives of this randomized trial are to define the maximum tolerated dose of radiation therapy, at curative dose levels, that can be delivered following…”
    Get more information
    Journal Article
  13. 13

    Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy by Kligerman, M M, Turrisi, 3rd, A T, Urtasun, R C, Norfleet, A L, Phillips, T L, Barkley, T, Rubin, P

    “…This is the final report of the Phase I Protocol for the initial clinical study of Multiple Dose WR-2721 with radiotherapy (RTOG 80-02). The essential object…”
    Get more information
    Journal Article
  14. 14

    Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent) by Glover, D, Riley, L, Carmichael, K, Spar, B, Glick, J, Kligerman, M M, Agus, Z S, Slatopolsky, E, Attie, M, Goldfarb, S

    Published in The New England journal of medicine (10-11-1983)
    “…We investigated the causes of the hypocalcemia associated with WR-2721, an investigational drug that protects normal tissues against the toxic effects of…”
    Get more information
    Journal Article
  15. 15

    Toxicity of WR-2721 administered in single and multiple doses by Kligerman, M M, Glover, D J, Turrisi, A T, Norfleet, A L, Yuhas, J M, Coia, L R, Simone, C, Glick, J H, Goodman, R L

    “…Two hundred forty-three patients have received WR-2721 in Phase I-II studies. Separate studies were conducted in which patients with advanced malignancies…”
    Get more information
    Journal Article
  16. 16

    Association of Neighborhood Design and Recreation Environment Variables with Physical Activity and Body Mass Index in Adolescents by Kligerman, Morton, Sallis, James F., Ryan, Sherry, Frank, Lawrence D., Nader, Philip R.

    Published in American journal of health promotion (01-03-2007)
    “…Purpose. To examine associations of neighborhood walkability and recreation environment variables with physical activity in adolescents. Methods. The…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Diagnostic imaging aids to head and neck radiation oncology by Tamler, B J, Kligerman, M M

    Published in Neuroimaging clinics of North America (01-05-1996)
    “…Tumors of the head and neck are primary sites for radiation treatment. In combination with surgery, the role of radiation is further expanded; however,…”
    Get more information
    Journal Article
  19. 19

    Human pharmacokinetics of WR-2721 by Shaw, L M, Turrisi, A T, Glover, D J, Bonner, H S, Norfleet, A L, Weiler, C, Kligerman, M M

    “…The pharmacokinetic properties of WR-2721 were investigated in 13 cancer patients given a 150 mg/M2 intravenous bolus dose of the drug. An average plasma…”
    Get more information
    Journal Article
  20. 20

    Factors Influencing the Oxidation of the Radioprotector WR-1065 by Tahsildar, Hassan I., Biaglow, John E., Kligerman, Morton M., Varnes, Marie E.

    Published in Radiation research (01-02-1988)
    “…N-(2-Mercaptoethyl)-1,3-diaminopropane (WR-1065) is the free thiol form of the radio- and chemoprotector S-2-(aminopropylamino)ethylphosphorothioic acid…”
    Get full text
    Journal Article